Elias Fattal is a full professor of Pharmaceutical Technology at the University of Paris-Sud 11 in Châtenay-Malabry, France and has been President of APGI since 2003. He received his Pharmacy Degree (1983), and Ph.D. (1990) from the University of Paris-Sud 11. After visiting the Department of Pharmaceutical Chemistry, University of California, San Francisco for a post-doctoral position (1990-1991), he became associate Professor (1992) and full Professor at the University of Paris-Sud 11 (2000). Elias Fattal is the director of the UMR CNRS 8612 where he is also leading one of the research group “Drug targeting and delivery of poorly stable drugs”. His research activity deals with the design of nano and microtechnologies for the delivery of peptides/proteins, nucleic acids and for imaging contrast agents. He is the author and co-author of around 170 publications and book chapters and 12 patents. In 1999, he received the Colloidal Drug Carrier Award (created for the 5th Expert meeting on colloidal drug carriers, Berlin, Germany) and the Pharmaceutical Sciences World Congress (PSWC) Research Achievement Award in 2007. He has also been elected Honour member of APV (Arbeitsgemeinschaft Pharmazeutische Verfahrenstechnik) in 2005. He is corresponding member of the French national Academy of Pharmacy. Elias Fattal is the co-editor of the journal of drug delivery science and technology. He serves in the editorial board of several Pharmaceutical Journals (Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences, and Expert Opinion on Drug Delivery) and nanotechnologies dedicated journals (NanoBiotechnology, International Journal of Nanomedecine).
June 2013 M T W T F S S « Mar 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
- Smart oral delivery systems can support the fight against antibiotic resistance
- Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells
- Calixarene nanoemulsion for uranium skin decontamination
- Lipoplexes targeting the CD 44 receptor
- Perfluorooctyl Bromide Polymeric Capsules as Dual Contrast Agents for Ultrasonography and Magnetic Resonance Imaging